HTLV-1 Tax-induced NF-κB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: Mechanism and implications for Tax oncogenicity

Journal of Molecular Medicine

Volumn 86, Issue 7, 2008, Pages 799-814

  Azran Shaish, Inbal ^a   Tabakin Fix, Yulia ^a   Huleihel, Mahmoud ^a   Bakhanashvili, Mary ^b   Aboud, Mordechai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

CBP; HTLV 1 Tax; NF B; p65; PKC; TPA

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIMER; HISTONE ACETYLTRANSFERASE PCAF; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMIN B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN P50; SYNAPTOTAGMIN I; TAX PROTEIN;

ARTICLE; CANCER RISK; CARCINOGENICITY; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN DNA BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; VIRUS CELL INTERACTION;

BASE SEQUENCE; CARCINOGENS; CELL LINE; CREB-BINDING PROTEIN; CYTOPLASM; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 46149093204     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-008-0335-1     Document Type: Article

References (45)

1. Schmitz ML, Mattioli I, Buss H, Kracht M (2004) NF-kB: a multifaceted transcription factor regulated at several levels. Chembiochem 5:1348-1358
2. Pahl HL (1999) Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18:6853-6866
3. Santoro MG, Rossi A, Amici C (2003) NF-TaxD58 B and virus infection: who controls whom. EMBO J 22:2552-2560
4. Radhakrishnan SK, Kamalakaran S (2006) Pro-apoptotic role of NF-kB: implications for cancer therapy. Biochim Biophys Acta 1766:53-62
5. Perkins ND, Gilmore TD (2006) Good cop, bad cop: the different faces of NF-kB. Cell Death Differ 13:759-772
6. Sheppard K-A, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T (1999) Transcriptional activation by NF-kB requires multiple coactivators. Mol Cell Biol 19:6367-6378
7. Zhong H, May MJ, Jimi E, Ghosh S (2002) The phosphorylation status of nuclear NF-kB determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625-636
8. Azran I, Schavinsky-Khrapunsky Y, Aboud M (2004) Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 1:20-43
9. Peloponese JM, Yeung ML, Jeang KT (2006) Modulation of nuclear factor-kB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 34:1-12
10. Horie R, Watanabe T, Umezawa K (2006) Blocking NF-kB as a potential strategy to treat adult T-cell leukemia/lymphoma. Drug News Perspect 19:201-209
11. Bex F, Yin MJ, Burny A, Gaynor RB (1998) Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol 18:2392-2405
12. Azran I, Jeang KT, Aboud M (2005) High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-kB-CBP ternary complex in the cytoplasm. Oncogene 24:4521-4530
13. Bex F, McDowall A, Burny A, Gaynor RB (1997) The human T-cell leukemia virus type-I transactivator protein Tax colocalizes in unique structures with NF-kB proteins. J Virol 71:3484-3497
14. Bex F, Gaynor RB (1998) Regulation of gene expression by HTLV-I Tax protein. Methods 16:83-94
15. Jeang KT (2001) Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kB. Cytokine Growth Factor Rev 12:207-217
16. O'Mahony A, Montano M, Van Beneden K, Chen LF, Greene WC (2004) Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-kB requires IkB kinase-1-mediated phosphorylation of RelA/p65. J Biol Chem 279:18137-18145
17. Kuo Y, Tang Y, Harrod R, Cai P, Giam CZ (2000) Kinase-inducible domain-like region of HTLV type 1 tax is important for NF-kappaB activation. AIDS Res Hum Retroviruses 16:1607-1612
18. Hecker E, Schmidt R (1974) Phorbolesters-the irritants and cocarcinogens of Croton tiglium L. Fortschr Chem Org Naturst 31:377-467
19. Barry OP, Kazanietz MG (2001) Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Design 7:1725-1744
20. Koivunen J, Aaltonen V, Peltonen J (2006) Protein kinase C (PKC) family in cancer progression. Cancer Lett 235:1-10
21. Lam PT, Chan KS, Tse CY, Leung MW (2005) Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections. J Pain Symptom Manage 30:536-543
22. Kawanishi S, Hiraku Y (2006) Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8:1047-1058
23. Serova M, Ghoul A, Benhadji KA, Cvitkovic E, Faivre S, Calvo F, Lokiec F, Raymond E (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 33:466-478
24. Carter CA (2000) Protein kinase C as a drug target implications for drug or diet prevention and treatment of cancer. Curr Drug Targets 1:163-183
25. Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A, Holden NS, Bergmann MW, Barnes PJ, Newton R (2004) Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream NF-kB DNA binding. J Biol Chem 279:18457-18466
26. Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI (2004) Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kB activation at multiple steps in Jurkat T cells. FASEB J 18:167-169
27. Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, Wigdahl B (2002) Human T cell leukemia virus type I and neurologic diseases: events in bone marrow, peripheral blood and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 190:133-159
28. Manel N, Battini JL, Taylor N, Sitbon M (2005) HTLV-1 tropism and envelope receptor. Oncogene 24:6016-6025
29. Torgeman A, Ben-Aroya Z, Grunspan A, Zelin E, Butovsky E, Hallak M, Lochelt M, Flugel RM, Livneh E, Wolfson M, Kedar I, Aboud M (2001) Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I infected T-cells from apoptosis by the viral Tax protein. Exptl Cell Res 271:169-179
30. Nagata K, Ohtani K, Nakamura M, Sugamura K (1989) Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol 63:3220-3226
31. Smith MR, Green WC (1990) Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotype. Gene Dev 4:1875-1885
32. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y, Giam C-Z (1998) An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol Cell Biol 18:5052-5061
33. Sun S, Elwood J, Greene W (1996) Both amino- and carboxyl-terminal sequences within IkBa regulate its inducible degradation. Mol Cell Biol 16:1058-1065
34. Livneh E, Shimon T, Bechor E, Doki Y, Schieren I, Weinstein IB (1996) Linking protein kinase C to the cell cycle: ectopic expression of PKCh in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene 12:1545-1555
35. Wu KK (2006) Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol Biol 338:281-290
36. Rambaratsingh RA, Stone JC, Blumberg PM, Lorenzo PS (2003) RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes. J Biol Chem 278:52792-52801
37. Torgeman A, Mor-Vaknin N, Zelin E, Ben-Aroya Z, Lochelt M, Flugel RM, Aboud M (2001) Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 281:10-20
38. Lindholm P, Tamami M, Makowski J, Brady J (1996) Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kB: involvement of the protein kinase C pathway. J Virol 70:2525-2532
39. Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K, Hinuma Y (1987) Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J 6:389-395
40. Ohtani K, Tsujimoto A, Tsukahara T, Numata N, Miura S, Sugamura K, Nakamura M (1998) Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. J Biol Chem 273:14119-14129
41. Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, Zeichner SL (2001) Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kB activation. Oncogene 20:4484-4496
42. Jeong EM, Moon CH, Kim CS, Lee SH, Baik EJ, Moon CK, Jung YS (2004) Cadmium stimulates the expression of ICAM-1 via NF-kB activation in cerebrovascular endothelial cells. Biochem Biophys Res Commun 320:887-892
43. Hyun JS, Satsu H, Shimizu M (2007) Cadmium induces interleukin-8 production via NF-kB activation in the human intestinal epithelial cells, Caco-2. Cytokine 37:26-34
44. Campbell KJ, Perkins ND (2006) Regulation of NF-kB function. Biochem Soc Symp 73:165-180
45. Natarajan M, Nayak BK, Galindo C, Mathur SP, Roldan FN, Meltz ML (2006) Nuclear translocation and DNA-binding activity of NF-kB after exposure of human monocytes to pulsed ultra-wideband electromagnetic fields (1 kV/cm) fails to transactivate kB-dependent gene expression. Radiat Res 165:645-654